• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

View This Comprehensive Strategic Analysis of the Latest Trends in the World Market for OTC Healthcare With an Overview of 14 Product Sectors

Posted on: Wednesday, 18 January 2006, 12:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c10681) has announced the addition of The World Market for OTC Healthcare to their offering.

In 2004, the global OTC healthcare market saw further growth, with the largest incremental growth derived from the three major regions -- Asia-Pacific, Western Europe and North America -- although to a certain extent growth in US dollar terms was exaggerated due to the strength of international currencies against the dollar in 2004. However, growth in percentage terms was also boosted by real growth in the developing regions of Eastern Europe and Africa and the Middle East.

This report on the world market for OTC healthcare provides comprehensive strategic analysis of the latest trends in the market, as well as an overview of 14 product sectors, the major national and high growth markets and major companies. Sales of OTC healthcare are analysed at both world and regional levels, as well as in over 50 individual countries. The sales period under review is 1999-2004, with forecasts to 2009.

Sector coverage: analgesics, cough, cold and allergy products, digestive remedies, medicated skin care, vitamins and dietary supplements, smoking cessation aids, eye care, calming and sleeping products, wound treatments, OTC obesity products, OTC statins, emergency contraception

The report comprises the following sections:

-- The State of the Market 2004

-- Operating Environment

-- Key Trends and Developments

-- World Market Overview

-- Analgesics

-- Cough, Cold and Allergy Remedies

-- Digestive Remedies

-- Medicated Skin Care

-- Vitamins and Dietary Supplements

-- Smoking Cessation Aids

-- Eye Care

-- Calming and Sleeping Products

-- Wound Treatments

-- OTC Obesity

-- Emergency Contraception

-- OTC Statins

-- Corporate Strategies

-- Distribution

-- Outlook

Companies mentioned in this report include:

-- Allergan Inc

-- Alticor Inc

-- American Home Products Corp

-- Angelini Group

-- Apollo Advisors LP

-- Arzneimittel Gesellschaft

-- Asahi Breweries Ltd

-- Bausch & Lomb Inc

-- Bayer AG

-- Beiersdorf AG

-- Boehringer Sohn, CH

-- Boots Co Plc, The

-- Bristol-Myers Squibb Co

-- Cadbury Schweppes Plc

-- Chattem Inc

-- Chugai Pharmaceutical Co Ltd

-- Daewoong Pharmaceutical Co Ltd

-- Daiichi Pharmaceutical Co Ltd

-- Dr Willmar Schwabe GmbH & Co

-- Fancl Corp

-- Farmaceutica SpA

-- Glaxo SmithKline Plc

-- Guizhou Convene Pharm

-- Herbalife International Inc

-- Hexal AG

-- Hisamitsu Pharmaceutical Co Inc

- Ivax Corp 2

-- Johnson & Johnson Inc

-- Jolly-Jattel SARL

-- - Kanro Co Ltd

-- Kobayashi Pharmaceutical Co Ltd

-- Kowa Co Ltd

-- Kyushin Pharmaceutical Co Ltd

-- Lek Pharmaceuticals

-- Lofthouse of Fleetwood Ltd

-- L'Oreal Groupe

-- Lotte Group

-- Merck KGaA

-- Merckle GmbH

-- Miki Corp

-- NBTY Inc

-- Nestle SA

-- Novartis AG

-- Nu Skin Enterprises Inc

-- Otsuka Pharmaceutical Co Ltd

-- Pfizer Inc

-- Pharmacia Corp

-- Pierre Fabre SA, Laboratoires

-- Prestige Brands Inc

-- Procter & Gamble Co, The

-- Reckitt Benckiser Plc

-- Recordati Industria Chimica

-- Ricola AG

-- Roche Holding AG

-- Rohto Pharmaceutical Co Ltd

-- Royal Numico NV

-- Sankyo Co Ltd

-- Sanofi-Aventis

-- Sanofi-Synthelabo France

-- Santen Pharmaceutical Co Ltd

-- Sato Pharmaceutical Co Ltd

-- Schering-Plough Corp

-- Solvay SA

-- Stada Arzneimittel AG

-- Steiner & Co Deutsche

-- Stiefel Laboratories Inc

-- Taisho Pharmaceutical Co Ltd

-- Takeda Chemical Industries Ltd

-- Tanabe Seiyaku Co Ltd

-- Technology Co

-- Tianjin Well Advanced Science &

-- United Laboratories Inc

-- Wyeth

-- Zenyaku Kogyo Co Ltd

-- Zeria Pharmaceutical Co Ltd

For more information visit http://www.researchandmarkets.com/reports/c10681

Source: Business Wire

More News in this Category